Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC39A13 antisense RNA 1 (SLC39A13-AS1), also known as LOUP or “long noncoding RNA originating from the URE of PU.1,” is a long noncoding RNA transcribed antisense to the SLC39A13 locus and upstream of the transcription factor PU.1 (encoded by SPI1). SLC39A13-AS1/LOUP functions as a regulatory RNA controlling the expression of PU.1, a master regulator of myeloid development, by acting specifically in myeloid lineages to enable efficient transcriptional activation of PU.1 from a distal enhancer. It is not a protein, receptor, or “druggable” target in the classical sense, but it does modulate critical biological processes governing hematopoietic differentiation and has implications for hematopoietic cancers and immune cell development. In summary, SLC39A13-AS1 is a functionally relevant lncRNA, central to the regulation of PU.1, with emerging possible roles in cancer biology, but is not a classical target such as a small-molecule receptor or enzyme. No therapeutics or drugs presently target this RNA.
Not applicable for drugs, since none are known. For biological mechanism: Functions primarily through regulation of adjacent gene transcription (particularly PU.1/SPI1) by mechanisms typical of lncRNAs: cis-regulatory chromatin effects, possibly as a scaffold or through RNA–protein interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SLC39A13 antisense RNA 1 (SLC39A13-AS1).